Genetic Marker Predicts Response to Hepatitis C Treatment

Duke University Medical Center researchers report in Nature that the marker is a single letter change -- a C instead of a T -- in a segment of DNA near the IL28B gene.

The journal Nature published a study Aug. 16 identifying a genetic marker that predicts how well patients will respond to treatment for Hepatitis C, which affects an estimated 170 million people and is among the world's most common infections. It is the leading cause of liver transplants in the United States. Duke University Medical Center researchers said patients found to have a C instead of a T in a segment of DNA near the IL28B gene were significantly more likely to respond favorably to treatment than those lacking it.

"Eighty percent of those with the favorable response genotype eradicated the virus, while only about 30 percent with the less favorable response genotype did so," David B. Goldstein, Ph.D., director of the Center for Human Genome Variation in Duke's Institute for Genome Sciences & Policy and senior author of the study, said in a news release posted by the medical school. "With differences of that magnitude, patients considering therapy may want to know what their genotype is before they start treatment."

"This discovery appears to explain a large part of it. It is most certainly a triumph of translational medicine," added Dr. John McHutchison, M.D., associate director of the Duke Clinical Research Institute and study co-author.

They said the "good" genotype also explains previously puzzling differences in treatment response between population groups. "Because it appears significantly more often among Caucasian populations than it does among African populations, we feel it explains much of the difference in response rates we see between African-Americans and those of European ancestry," Goldstein said. "This tells us that individual genetic makeup is much more important determinant of response to treatment than is race or ethnicity."

Having the "good" genotype also meant there was lower viral load -- a measure of how much virus circulated in the patient before treatment -- than in patients without it, they reported. Some people with Hepatitis C do not require treatment, but those who do are given 24 or 48 weeks of interferon and an antiviral. This clears the infection in fewer than half of the people with the most common form of Hepatitis C.

The study was funded by the Schering-Plough Research Institute.

Download Center

  • Safety Metrics Guide

    Is your company leveraging its safety data and analytics to maintain a safe workplace? With so much data available, where do you start? This downloadable guide will give you insight on helpful key performance indicators (KPIs) you should track for your safety program.

  • Job Hazard Analysis Guide

    This guide includes details on how to conduct a thorough Job Hazard Analysis, and it's based directly on an OSHA publication for conducting JHAs. Learn how to identify potential hazards associated with each task of a job and set controls to mitigate hazard risks.

  • A Guide to Practicing “New Safety”

    Learn from safety professionals from around the world as they share their perspectives on various “new views” of safety, including Safety Differently, Safety-II, No Safety, Human and Organizational Performance (HOP), Resilience Engineering, and more in this helpful guide.

  • Lone Worker Safety Guide

    As organizations digitalize and remote operations become more commonplace, the number of lone workers is on the rise. These employees are at increased risk for unaddressed workplace accidents or emergencies. This guide was created to help employers better understand common lone worker risks and solutions for lone worker risk mitigation and incident prevention.

  • EHS Software Buyer's Guide

    Learn the keys to staying organized, staying sharp, and staying one step ahead on all things safety. This buyer’s guide is designed for you to use in your search for the safety management solution that best suits your company’s needs.

  • Vector Solutions

Featured Whitepaper

OH&S Digital Edition

  • OHS Magazine Digital Edition - May 2022

    May 2022

    Featuring:

    • WEARABLE TECHNOLOGY
      How Wearable Technology is Transforming Safety and the Industrial Workplace
    • TRAINING: CONFINED SPACES
      Five Tips to Improve Safety in Confined Spaces
    • INDUSTRIAL HYGIENE
      Monitor for Asbestos to Help Save Lives
    • PPE: FALL PROTECTION
      Fall Protection Can Be Surprising
    View This Issue